Enablers and barriers to implementing obesity assessments in clinical practice: a rapid mixed-methods systematic review.
PREVENTIVE MEDICINE
PRIMARY CARE
QUALITATIVE RESEARCH
Quality in health care
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
29 11 2022
29 11 2022
Historique:
entrez:
29
11
2022
pubmed:
30
11
2022
medline:
2
12
2022
Statut:
epublish
Résumé
This systematic review aims to improve our knowledge of enablers and barriers to implementing obesity-related anthropometric assessments in clinical practice. A mixed-methods systematic review. Medline, Embase and CINAHL to November 2021. Quantitative studies that reported patient factors associated with obesity assessments in clinical practice (general practice or primary care); and qualitative studies that reported views of healthcare professionals about enablers and barriers to their implementation. We used random-effects meta-analysis to pool ratios for categorical predictors reported in ≥3 studies expressed as pooled risk ratio (RR) with 95% CI, applied inverse variance weights, and investigated statistical heterogeneity (I We reviewed 22 quantitative (observational) and 3 qualitative studies published between 2004 and 2020. All had ≥50% of the quality items for risk of bias assessments. Obesity assessment in clinical practice was positively associated with patient factors: female sex (RR 1.28, 95% CI 1.10 to 1.50, I Our evidence synthesis revealed several important enablers and barriers to obesity assessments that should inform healthcare professionals and relevant stakeholders to encourage adherence to clinical practice guideline recommendations.
Identifiants
pubmed: 36446466
pii: bmjopen-2022-063659
doi: 10.1136/bmjopen-2022-063659
pmc: PMC9710371
doi:
Types de publication
Systematic Review
Meta-Analysis
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e063659Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: EA was the Founding President, and now serves as the Secretary, of the National Association of Clinical Obesity Services (NACOS). He has received honoraria from Novo Nordisk for speaking and participating at meetings. He has received unrestricted research funding from Novo Nordisk and iNova on behalf of NACOS. RC and CNS have received payments for their contributions through casual employment contracts at Western Sydney University. PF, KP, GM, BC and DL declare no competing financial interests.
Références
Med J Aust. 2015 Apr 20;202(7):370-2
pubmed: 25877119
Obes Res Clin Pract. 2015 Jul-Aug;9(4):408-15
pubmed: 26359306
Obes Rev. 2019 Sep;20(9):1218-1230
pubmed: 31286668
Heart. 2016 Dec 15;102(24):1957-1962
pubmed: 27534979
Fam Pract. 2009 Oct;26(5):365-71
pubmed: 19589884
J Med Internet Res. 2021 Jun 28;23(6):e25529
pubmed: 34075879
Clin Obes. 2018 Jun;8(3):203-210
pubmed: 29683555
Diabetes Obes Metab. 2019 Aug;21(8):1914-1924
pubmed: 31032548
Aust Fam Physician. 2016 Oct;45(10):702-705
pubmed: 27695717
BMJ Health Care Inform. 2019 Jun;26(1):
pubmed: 31196930
Endocrinol Nutr. 2014 Nov;61(9):469-73
pubmed: 24846816
Popul Health Manag. 2018 Jun;21(3):222-230
pubmed: 28949834
NCHS Data Brief. 2020 Feb;(360):1-8
pubmed: 32487284
JAMA Intern Med. 2013 Sep 23;173(17):1648-52
pubmed: 23835808
BMC Med Inform Decis Mak. 2007 Jun 15;7:16
pubmed: 17573961
Fam Pract. 2011 Feb;28(1):34-40
pubmed: 20802243
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
BMC Fam Pract. 2019 Dec 13;20(1):173
pubmed: 31836016
BMC Med. 2015 Sep 16;13:224
pubmed: 26377409
BMC Health Serv Res. 2009 Dec 16;9:236
pubmed: 20015391
Schizophr Res. 2011 Jul;129(2-3):104-10
pubmed: 21550783
BMC Fam Pract. 2018 Nov 17;19(1):174
pubmed: 30447691
BMC Med. 2019 Nov 29;17(1):222
pubmed: 31783757
Contemp Clin Trials. 2015 Nov;45(Pt A):130-8
pubmed: 26003435
Obes Rev. 2020 Jan;21(1):e12949
pubmed: 31675146
Diabetes Care. 2015 Aug;38(8):1567-82
pubmed: 26421334
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720967221
pubmed: 33111633
Fam Med. 2016 Mar;48(3):217-21
pubmed: 26950911
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Aust J Rural Health. 2016 Aug;24(4):246-52
pubmed: 26694898
Lancet. 2016 May 7;387(10031):1947-56
pubmed: 26868660
PLoS One. 2021 Oct 28;16(10):e0259220
pubmed: 34710172
J Gen Intern Med. 2005 Dec;20(12):1139-41
pubmed: 16423105
BMJ Glob Health. 2019 Jan 25;4(Suppl 1):e000893
pubmed: 30775016
Appl Clin Inform. 2017 Jan 25;8(1):67-79
pubmed: 28119990
Obes Rev. 2019 Nov;20 Suppl 2:185-193
pubmed: 31317659
Am J Public Health. 2004 Dec;94(12):2084-90
pubmed: 15569958
Patient Educ Couns. 2011 Jan;82(1):123-9
pubmed: 20303691
Int J Obes Relat Metab Disord. 2004 Oct;28(10):1299-308
pubmed: 15314629
BMJ Open. 2020 Mar 9;10(3):e034023
pubmed: 32156764
Clin Obes. 2019 Jun;9(3):e12301
pubmed: 30761766
J Gen Intern Med. 2014 Feb;29(2):328-34
pubmed: 24101533
Obes Rev. 2021 Apr;22(4):e13151
pubmed: 33283435
Obes Res Clin Pract. 2020 Sep - Oct;14(5):487-490
pubmed: 32888856
J Public Health (Oxf). 2013 Mar;35(1):67-74
pubmed: 22829663
Am J Manag Care. 2009 Sep;15(9):619-24
pubmed: 19747026
Syst Rev. 2017 Mar 23;6(1):61
pubmed: 28335799
Nat Med. 2020 Apr;26(4):485-497
pubmed: 32127716